Cargando…

Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study

The aim of the study was to assess the effect of a booster dose of COVID-19 vaccine on the rates of hospital ward and intensive care unit (ICU) admissions around the time of emergence of the Omicron variant in the Basque Country. A retrospective cohort population-based study was conducted. The popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrospide, A., Sagardui, M.G., Larizgoitia, I., Iturralde, A., Moreda, A., Mar, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227462/
https://www.ncbi.nlm.nih.gov/pubmed/37271704
http://dx.doi.org/10.1016/j.vaccine.2023.05.061
_version_ 1785050777950093312
author Arrospide, A.
Sagardui, M.G.
Larizgoitia, I.
Iturralde, A.
Moreda, A.
Mar, J.
author_facet Arrospide, A.
Sagardui, M.G.
Larizgoitia, I.
Iturralde, A.
Moreda, A.
Mar, J.
author_sort Arrospide, A.
collection PubMed
description The aim of the study was to assess the effect of a booster dose of COVID-19 vaccine on the rates of hospital ward and intensive care unit (ICU) admissions around the time of emergence of the Omicron variant in the Basque Country. A retrospective cohort population-based study was conducted. The population with any records related to COVID-19 vaccination up to 28 February 2022 was classified into four cohorts by vaccination status. For every cohort, the hospital ward and ICU admission rates were calculated for each day between November 2021 and February 2022. Generalized linear models with a negative binomial distribution were used to estimate the age-adjusted hospitalization rate ratio of the cohort of individuals who had received a booster compared to the other cohorts. The age-adjusted rates of hospital ward and ICU admissions were 70.4 % and 72.0 % lower, respectively, in the fully vaccinated plus booster group compared to the fully vaccinated but no booster group. Analysing changes in the 14-day admission incidence rates showed that as the prevalence of the Omicron variant increased, the corresponding rate ratios decreased. The immunity acquired with the booster dose allowed the hospital network to meet all the demand for hospitalization during a period of high incidence of COVID-19, despite the fact that vaccine protection decreased as the prevalence of the Omicron variant increased.
format Online
Article
Text
id pubmed-10227462
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-102274622023-05-30 Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study Arrospide, A. Sagardui, M.G. Larizgoitia, I. Iturralde, A. Moreda, A. Mar, J. Vaccine Article The aim of the study was to assess the effect of a booster dose of COVID-19 vaccine on the rates of hospital ward and intensive care unit (ICU) admissions around the time of emergence of the Omicron variant in the Basque Country. A retrospective cohort population-based study was conducted. The population with any records related to COVID-19 vaccination up to 28 February 2022 was classified into four cohorts by vaccination status. For every cohort, the hospital ward and ICU admission rates were calculated for each day between November 2021 and February 2022. Generalized linear models with a negative binomial distribution were used to estimate the age-adjusted hospitalization rate ratio of the cohort of individuals who had received a booster compared to the other cohorts. The age-adjusted rates of hospital ward and ICU admissions were 70.4 % and 72.0 % lower, respectively, in the fully vaccinated plus booster group compared to the fully vaccinated but no booster group. Analysing changes in the 14-day admission incidence rates showed that as the prevalence of the Omicron variant increased, the corresponding rate ratios decreased. The immunity acquired with the booster dose allowed the hospital network to meet all the demand for hospitalization during a period of high incidence of COVID-19, despite the fact that vaccine protection decreased as the prevalence of the Omicron variant increased. Elsevier Ltd. 2023-06-29 2023-05-29 /pmc/articles/PMC10227462/ /pubmed/37271704 http://dx.doi.org/10.1016/j.vaccine.2023.05.061 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Arrospide, A.
Sagardui, M.G.
Larizgoitia, I.
Iturralde, A.
Moreda, A.
Mar, J.
Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study
title Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study
title_full Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study
title_fullStr Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study
title_full_unstemmed Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study
title_short Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study
title_sort effectiveness of the booster dose of covid-19 vaccine in the basque country during the sixth wave: a nationwide cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227462/
https://www.ncbi.nlm.nih.gov/pubmed/37271704
http://dx.doi.org/10.1016/j.vaccine.2023.05.061
work_keys_str_mv AT arrospidea effectivenessoftheboosterdoseofcovid19vaccineinthebasquecountryduringthesixthwaveanationwidecohortstudy
AT sagarduimg effectivenessoftheboosterdoseofcovid19vaccineinthebasquecountryduringthesixthwaveanationwidecohortstudy
AT larizgoitiai effectivenessoftheboosterdoseofcovid19vaccineinthebasquecountryduringthesixthwaveanationwidecohortstudy
AT iturraldea effectivenessoftheboosterdoseofcovid19vaccineinthebasquecountryduringthesixthwaveanationwidecohortstudy
AT moredaa effectivenessoftheboosterdoseofcovid19vaccineinthebasquecountryduringthesixthwaveanationwidecohortstudy
AT marj effectivenessoftheboosterdoseofcovid19vaccineinthebasquecountryduringthesixthwaveanationwidecohortstudy